Katharine E. Spink
Operationeel Directeur bij Dark Horse Consulting Group, Inc.
Actieve functies van Katharine E. Spink
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Dark Horse Consulting Group, Inc.
 Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Operationeel Directeur | 01-01-2018 | - |
Loopbaan van Katharine E. Spink
Eerdere bekende functies van Katharine E. Spink
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Operationeel Directeur | 01-03-2013 | 19-01-2018 |
| Cardiovascular Disease Foundation, Inc. | Corporate Officer/Principal | 01-01-2003 | 01-01-2008 |
| GERON CORPORATION | Operationeel Directeur | 01-12-2003 | - |
Opleiding van Katharine E. Spink
| Rice University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Operating Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
| Cardiovascular Disease Foundation, Inc. | |
Dark Horse Consulting Group, Inc.
Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Commercial Services |
- Beurs
- Insiders
- Katharine E. Spink
- Ervaring
